CLINICAL_TRIALS
trial_result
· 2012-01-13
Clinical Trial Update: Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke [Phase 1, Phase 2]
Summary
An update on a neuroprotective drug evaluated in Phase 1/2 trials to limit brain damage from acute ischemic stroke, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: David Hess, MD | Conditions: Stroke, Acute | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-01-13